686 related articles for article (PubMed ID: 29526657)
1. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
2. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
Kübler D; Schroll H; Buchert R; Kühn AA
J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
[TBL] [Abstract][Full Text] [Related]
3. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
[TBL] [Abstract][Full Text] [Related]
4. Association of the Non-Motor Burden with Patterns of Striatal Dopamine Loss in de novo Parkinson's Disease.
Chung SJ; Lee S; Yoo HS; Lee YH; Lee HS; Choi Y; Lee PH; Yun M; Sohn YH
J Parkinsons Dis; 2020; 10(4):1541-1549. PubMed ID: 32925098
[TBL] [Abstract][Full Text] [Related]
5. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.
Jeong SH; Lee HS; Jung JH; Baik K; Sohn YH; Chung SJ; Lee PH
Parkinsonism Relat Disord; 2022 Apr; 97():1-7. PubMed ID: 35276583
[TBL] [Abstract][Full Text] [Related]
6. Processing speed is related to striatal dopamine transporter availability in Parkinson's disease.
Vriend C; van Balkom TD; van Druningen C; Klein M; van der Werf YD; Berendse HW; van den Heuvel OA
Neuroimage Clin; 2020; 26():102257. PubMed ID: 32344372
[TBL] [Abstract][Full Text] [Related]
7. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
[TBL] [Abstract][Full Text] [Related]
8. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
[TBL] [Abstract][Full Text] [Related]
9. The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism.
Lee YH; Lee S; Chung SJ; Yoo HS; Jung JH; Baik K; Ye BS; Sohn YH; Yun M; Lee PH
Parkinsonism Relat Disord; 2021 Jan; 82():1-6. PubMed ID: 33220520
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
11. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
[TBL] [Abstract][Full Text] [Related]
12. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
13. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
[TBL] [Abstract][Full Text] [Related]
14. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
[TBL] [Abstract][Full Text] [Related]
15. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
[TBL] [Abstract][Full Text] [Related]
16. Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson's disease.
Jeong SH; Park CW; Lee HS; Kim YJ; Yun M; Lee PH; Sohn YH; Chung SJ
J Neural Transm (Vienna); 2023 Jan; 130(1):19-28. PubMed ID: 36462096
[TBL] [Abstract][Full Text] [Related]
17. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
[TBL] [Abstract][Full Text] [Related]
18. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
[TBL] [Abstract][Full Text] [Related]
20. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
